|
Volumn 58, Issue 12, 2012, Pages 666-677
|
Alzheimer's Disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALZHEIMER DISEASE VACCINE;
AMYLOID BETA PROTEIN[1-40];
AMYLOID BETA PROTEIN[1-42];
APOLIPOPROTEIN E;
CHOLINESTERASE INHIBITOR;
CYANOCOBALAMIN;
DONEPEZIL;
GALANTAMINE;
GLUCOSE;
GLUTAMATE RECEPTOR ANTAGONIST;
HOMOCYSTEINE;
MEMANTINE;
PRESENILIN 2;
RIVASTIGMINE;
ABDOMINAL DISCOMFORT;
ALLELE;
ALZHEIMER DISEASE;
APPLICATION SITE ERYTHEMA;
ARTICLE;
BRADYCARDIA;
BRAIN ATROPHY;
BRAIN ISCHEMIA;
CARDIOVASCULAR RISK;
CEREBROSPINAL FLUID;
CEREBROVASCULAR ACCIDENT;
CLINICAL FEATURE;
CONFUSION;
CONSTIPATION;
DIABETES MELLITUS;
DIARRHEA;
DIZZINESS;
DNA POLYMORPHISM;
DOWN SYNDROME;
DRUG ERUPTION;
DRUG INDUCED HEADACHE;
EXERCISE;
GASTROINTESTINAL SYMPTOM;
GENE MUTATION;
GLUCOSE BLOOD LEVEL;
HEAD INJURY;
HUMAN;
HYPERTENSION;
INSOMNIA;
MUSCLE CRAMP;
NAUSEA;
NAUSEA AND VOMITING;
NEUROIMAGING;
NEUROPATHOLOGY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OBESITY;
PROTEIN AGGREGATION;
PROTEIN CLEAVAGE;
RISK FACTOR;
SEX DIFFERENCE;
SMOKING;
VIVID DREAM;
ALZHEIMER DISEASE;
FEMALE;
HUMANS;
|
EID: 84869053472
PISSN: 00115029
EISSN: 15578194
Source Type: Journal
DOI: 10.1016/j.disamonth.2012.08.008 Document Type: Article |
Times cited : (12)
|
References (8)
|